CN110862445A - NtOEP1 gene influencing tobacco pigment content and application thereof - Google Patents

NtOEP1 gene influencing tobacco pigment content and application thereof Download PDF

Info

Publication number
CN110862445A
CN110862445A CN201911316510.9A CN201911316510A CN110862445A CN 110862445 A CN110862445 A CN 110862445A CN 201911316510 A CN201911316510 A CN 201911316510A CN 110862445 A CN110862445 A CN 110862445A
Authority
CN
China
Prior art keywords
ntoep1
gene
tobacco
content
pigment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911316510.9A
Other languages
Chinese (zh)
Other versions
CN110862445B (en
Inventor
徐国云
刘萍萍
周会娜
郑庆霞
张慧
翟妞
陈千思
金立锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Tobacco Research Institute of CNTC
Original Assignee
Zhengzhou Tobacco Research Institute of CNTC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Tobacco Research Institute of CNTC filed Critical Zhengzhou Tobacco Research Institute of CNTC
Priority to CN201911316510.9A priority Critical patent/CN110862445B/en
Publication of CN110862445A publication Critical patent/CN110862445A/en
Application granted granted Critical
Publication of CN110862445B publication Critical patent/CN110862445B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

The invention belongs to the technical field of tobacco genetic engineering, and particularly relates to a method for influencing the content of tobacco pigmentNtOEP1Genes and patent applications of the genes. The gene comprises 999 bp bases, wherein the 153 th-522 th nucleotide is a specific core fragment thereof, and the base sequence is shown as SEQ ID NO. 1; the coding sequence has 332 amino acids, and the amino acid sequence is shown in SEQ ID NO. 2. In this application, by treating tobaccoNtOEP1The gene has important application in the regulation and control of tobacco pigment synthesis path and is highly related to the content of pigment substances in plant leaves through cloning and analysis of the gene. Further by virusMediated Gene silencing techniques, the inventors have found thatNtOEP1After gene silencing, the content of pigment substances in the new transgenic plant is obviously reduced. By utilizing the characteristic, a new strategy and a new path can be provided for the genetic engineering breeding of tobacco or the breeding of other new plant varieties.

Description

NtOEP1 gene influencing tobacco pigment content and application thereof
Technical Field
The invention belongs to the technical field of tobacco genetic engineering, and particularly relates to a method for influencing the content of tobacco pigmentNtOEP1Genes and patent applications of the genes.
Background
The tobacco is used as a leaf economic crop, the cultivation technology of the tobacco is different from other field crops, a certain tobacco yield is required, and the quality of the tobacco is emphasized. The quality of the tobacco leaves determines the availability of the tobacco leaves, directly influences the color, the fragrance, the taste and the commodity value of the finished cigarette products, is also related to the economic benefit of tobacco growers, and is the life and the starting point of the tobacco industry.
The pigment is an important compound in the tobacco growth process and mainly comprises chlorophyll and carotenoid substances. Chlorophyll can be degraded and disappeared in a large amount in the processes of tobacco maturation and tobacco leaf modulation, and the main degradation modes are two types: one way is that chlorophyll is degraded by a porphyrin ring to generate pyrrole compounds, thereby increasing the aging fragrance of tobacco leaves; alternatively, phytol produced by hydrolysis of chlorophyll can be further degraded into neophytadiene and then into phytofurans, which are converted into the sweet components of tobacco leaves. Generally speaking, chlorophyll is beneficial to improving the quality of tobacco leaves after being fully degraded, but if the chlorophyll is not fully degraded, the chlorophyll becomes an unfavorable chemical component in dry tobacco leaves, and the tobacco leaves are obviously green and impure. If the chlorophyll is not fully degraded in the process of modulation treatment, the tobacco leaves are baked, and green and yellow tobacco with different degrees can be baked. The green and yellow tobacco has poor appearance quality and has obvious influence on the quality of tobacco leaves. Therefore, whether the chlorophyll is degraded sufficiently is one of the indexes which are strictly controlled in the tobacco leaf grading.
The yellow pigment in the tobacco leaves is mainly carotenoid, and generally, the carotenoid content in the tobacco leaves has positive correlation with the tobacco leaf quality, on one hand, the appearance quality of the tobacco leaves is directly correlated with the content of the components; on the other hand, the carotenoid is an important precursor of the tobacco aroma component, and has a positive correlation with the aroma quantity and the aroma quality of the tobacco. Studies show that a large part of flavor components in tobacco leaves are degradation products of carotenoids, and a plurality of compounds are key flavor components in the tobacco, such as ionone, damascone, isophorone and the like.
In a word, because the relation between the pigment substances in the tobacco leaves and the quality of the tobacco leaves is very close, the full and deep research on the genes related to the pigment substances of the tobacco leaves is realized, so that the pigment substances are controlled in a targeted manner, and the method has very important theoretical and application significance for improving the quality of the tobacco leaves and improving the varieties of the tobacco leaves.
Disclosure of Invention
The invention aims to provide a method for influencing the pigment content of tobaccoNtOEP1The gene can regulate and control the content of pigment substances in the tobacco, thereby laying a foundation for improving the quality of the tobacco.
The technical solution adopted in the present application is detailed as follows.
Influencing the pigment content of tobaccoNtOEP1The gene comprises 999 bp bases, wherein the 153 th-522 th nucleotide is a specific core fragment thereof, and the base sequence thereof is shown as SEQ ID NO. 1.
Said influencing of tobacco pigment contentNtOEP1Application of gene in regulation of leaf pigment content by regulating gene silencing technology or gene overexpression methodNtOEP1The gene expression quantity is used for regulating and controlling the content of the pigment substances in the leaves.
Said influencing of tobacco pigment contentNtOEP1The PCR amplification preparation method of the gene comprises the following steps:
(1) extracting (for example, taking tobacco K326 leaves as a sample) genome, and carrying out reverse transcription to obtain cDNA for later use;
(2) designing a primer for PCR amplification, and carrying out PCR amplification, wherein the specific primer sequence is designed as follows:
NtOEP1-F: 5'- ATGGCTGCCTCTCTACAAGC -3',
NtOEP1-R: 5'- TCATTCAAGTTGGGCATACC -3'。
silencing said effect on tobacco pigment contentNtOEP1Silencing vector TRV2-NtOEP1To do so byNTOEP1153 th-522 th nucleotide in the gene is used as a guide sequence of VIGS, and the nucleic acid fragment is inserted into a TRV2-LIC empty vector to construct and obtain TRV2-NTOEP1A carrier, in particular:
(1) PCR amplification
To be provided withNTOEP1153 th-522 th nucleotide in the gene is used as a guide sequence of VIGS, and a primer sequence for designing and amplifying is designed as follows:
NtOEP1-VI-F: 5'-TCGACGACAAGACCCTGCAGGCAAACTGAACTCAAGGACT -3',
NtOEP1-VI-R: 5'-TGAGGAGAAGAGCCCTGCAGAATCTCATCAAGGGTGTAGG-3';
among the above sequences, "TCGACGACAAGACCCTGCAG" partial sequence at the 5 'end of the F primer portion and "TGAGGAGAAGAGCCCTGCAG" at the 5' end of the R primer portion are the linker sequence of TRV2-LIC vector;
(2) enzyme digestion and connection
Using restriction endonucleasesPstI, carrying out single enzyme digestion on the TRV2-LIC plasmid, and then utilizing Infusion ligase to connect the single enzyme digestion product of the TRV2-LIC with the PCR amplification fragment in the step (1);
(3) transformation and screening
Transforming the ligation product in the step (2) into an Escherichia coli competent cell DH5 α, coating the Escherichia coli competent cell DH5 α on LB medium containing kanamycin (50 mg/L), carrying out overnight inverted culture at 37 ℃ for screening to form a single colony, and determining the correct recombinant single clone as the TRV2-NtOEP1A recombinant vector.
Influencing the pigment content of tobaccoNTOEP1The protein coded by the gene comprises 332 amino acids, and the amino acid sequence of the protein is shown as SEQ ID NO. 2.
Said influencing of tobacco pigment contentNTOEP1GeneThe coded protein is related to the content of the pigments in the plant leaves, and the content of the pigments in the leaves is obviously reduced after the expression content of the protein is reduced.
Using said influencing of tobacco pigment contentNtOEP1The new tobacco variety of gene is bred through interference, silencing, knockout or over expression of transgenic technology, instantaneous expression technology, genome editing technology, etcNtOEP1The gene can obtain a new variety of tobacco transformation plants with changed pigment content. Specific examples thereof include:
using virus-mediated gene silencing technology (VIGS) toNtOEP1153 th-522 th nucleotide in the gene is used as a guide sequence of VIGS, the nucleic acid fragment is inserted into a TRV2-LIC vector to construct and obtain TRV2-NtOEP1The vector is transformed into a plant and is obtained by screening and identifyingNtOEP1A gene-silenced plant, theNtOEP1The content of pigment substances in the gene silencing plants is obviously reduced.
In other words, a method for breeding a new variety of tobacco with low content of pigment substances by interfering with virus-induced gene silencing (VIGS)NtOEP1The expression of the gene causes it to be silenced,NtOEP1the pigment content in the plants of the new tobacco variety with the silent gene is obviously reduced.
In this application, by treating tobaccoNtOEP1The cloning of the gene and the analysis of the corresponding protein, the inventor finds that the gene has important application in the regulation of the tobacco pigment synthesis pathway and is highly related to the content of pigment substances in plant leaves. Further by the virus-mediated gene silencing technique, the inventors have found thatNtOEP1After gene silencing, the content of pigment substances in the new transgenic plant is obviously reduced. By utilizing the characteristic, a new strategy and a new path can be provided for the genetic engineering breeding of tobacco or the breeding of other new plant varieties.
Drawings
FIG. 1 compares to empty vector control plantsNtOEP1Relative expression of the gene in the gene-silenced plant;
FIG. 2 Virus induced silencingNtOEP1Post-gene tableAnd (4) type analysis.
Detailed Description
The present application is further illustrated by the following examples, and prior to describing the specific examples, the basic aspects of the biological materials, reagents, instruments, etc. involved in the examples described below are briefly described as follows.
Biological material:
tobacco material, cultivated tobacco: (Nicotiana tabacum) Variety K326, available from yuxi tobacco seeds llc; ben's cigarette (Ben's cigarette)Nicotiana benthamiana) The seeds are presented by the tobacco institute of Chinese academy of agricultural sciences;
vector plasmids TRV2-LIC (empty vector control), TRV1 and TRV2-PDSThe vector is purchased from China plasmid vector strain cell line gene collection center.
Gene sequencing and primer synthesis were performed by Shanghai Bioengineering Co., Ltd.
Experimental reagent:
restriction enzymes, dATP, dTTP, PrimeSTAR GXL DNA polymerase, DNA Gel recovery Kit MiniBEST Agarose Gel DNA Extraction Kit, plasmid DNA miniprep Kit MiniBEST plasmid purification Kit, acetosyringone, TAKARA biotechnology Limited products;
TRIZOL reagent for RNA extraction, manufactured by Invitrogen corporation;
reverse transcription kit, product of Roche company;
dnase enzyme, product of Fermentas corporation;
MES, product of Sigma;
insusion ligase, product of Clontech;
LB liquid medium (1L): 10 g bacterial peptone (bacteriological peptone), 10 g sodium chloride (NaCl), 5 g yeast extract (yeast extract), autoclaving;
1M 2- (N-morpholine) ethanesulfonic acid (MES) stock: ddH2Dissolving MES in O, filtering, sterilizing, and storing at-20 deg.C;
200 mM Acetosyringone (Acetosyringone) stock solution: dissolving acetosyringone with anhydrous ethanol, and storing at-20 deg.C;
an experimental instrument:
the PCR instrument has the following model: mastercycler ep gradient, Eppendorf, Germany.
Example 1
This example affects primarily the tobacco pigment contentNtOEP1The process of obtaining the gene is briefly described below.
Tobacco RNA extraction and cDNA synthesis
(1) Total RNA extraction
Taking young leaves of tobacco K326 growing for about 3 weeks as samples, and fully grinding the samples into powder by liquid nitrogen;
placing about 100 mg of the powdery material into a 1.5 ml centrifuge tube containing 1.0 ml of TRIZOL reagent, adding 200 μ l of chloroform, shaking, mixing, centrifuging, and carefully transferring the upper aqueous phase into another centrifuge tube;
adding 500 μ l isopropanol, precipitating, centrifuging to separate RNA, washing with 75% ethanol, slightly drying at room temperature, adding appropriate volume of RNase free water, and dissolving completely;
finally, the extracted total RNA is treated by DNase I for the subsequent preparation of cDNA, and when the total RNA is treated by DNase I digestion, the reference of a 10-mu L reaction system is as follows:
1 μ g of total RNA extracted;
10×reaction buffer with MgCl2,1 μl;
DNase I(RNase-free),1 μl (1U);
DEPC-treated water to 10. mu.l;
placing in water bath at 37 deg.C for 30 min.
(2) cDNA Synthesis
Preparing a template RNA/primer mixed solution in a sterile 0.2 ml centrifuge tube, rapidly quenching for more than 2 min on ice after preserving heat for 10 min at 70 ℃, and centrifuging for several seconds to enable a template RNA/primer denatured solution to be gathered at the bottom of the centrifuge tube;
the template RNA/primer mixed solution (7 mu l system) specifically comprises:
RNA (100 ng/. mu.l) digested by DNase I in the step (1), and 1. mu.l;
Oligo (dT) Primer (50 μM),1 μl;
RNase free dH2O,5 μl;
preparing a reverse transcription reaction solution in the centrifuge tube, and then preserving heat for 1 h at 42 ℃; keeping the temperature at 70 ℃ for 15 min, and cooling on ice to obtain cDNA;
the specific reverse transcription reaction solution system (10. mu.l) was:
7. mu.l of the above template RNA/primer denaturing solution;
5×M-MLV buffer,2 μl;
dNTP mix (10 mM each), 0.5. mu.l;
RNase Inhibitor (40 U/μl),0.25 μl;
RTase M-MLV (RNase H-) (200 U/μl),0.25 μl。
(3) PCR amplification
First, primer sequences for PCR amplification were designed as follows:
NtOEP1-F: 5'- ATGGCTGCCTCTCTACAAGC -3',
NtOEP1-R: 5'- TCATTCAAGTTGGGCATACC -3';
subsequently, PCR amplification was performed using the cDNA prepared in step (2) as a template, and a 50. mu.l amplification system was designed as follows:
cDNA template, 1. mu.l;
GXL polymerase,1 μl;
5×GXL buffer,10 μl;
dNTP Mixture (10 mM),4 μl;
Primer-F/R,8 μl;
ddH2O,26 μl;
the PCR reaction procedure is shown in the table below: at 98 ℃ for 10 sec; 55 deg.C, 10sec, 68 deg.C, 1min, 35 cycles, 72 deg.C extension for 5 min.
And (3) carrying out 1% agarose gel electrophoresis detection on the PCR product obtained by amplification, and then, recovering and purifying the PCR amplification product, and sequencing.
Sequencing results show that the clone of the application obtainsNtOEP1The gene comprises 999 bp bases, wherein the 153 th-522 th nucleotide is a specific core fragment thereof, and the base sequence is shown as SEQ ID NO.1 and specifically comprises the following steps:
ATGGCTGCCTCTCTACAAGCAGCTGCTACTCTAATGCAACCAACAAAGGTTGGTGTTGCCCCAGCTAGAAACAACCTGCAGTTGAGGTCTGCTCAAAGTGTGAGCAAAGCATTTGGTGTTGAACCAGCTGCAGCTAGGCTTACTTGCTCTTTGCAAACTGAACTCAAGGACTTGGCTCAAAAGTGCACTGATGCTGCCAAGGTTGCTGGTTTTGCTCTGGCCACTTCTGCCCTTGTCGTCTCAGGAGCAAATGCTGAAGGAGTTCCAAAACGTCTAACCTTCGACGAAATTCAAAGCAAGACATACATGGAAGTAAAGGGAACTGGAACTGCTAACCAGTGCCCTACGATAGAAGGAGGTGTTGCCAGCTTTGCCTTCAAGCCAGGCAAATACAATGCCAAGAAATTCTGCTTAGAGCCCACATCATTCACAGTCAAGGCAGAGAGTGTGAACAAGAATGCACCCCCAGATTTCCAGAAAACCAAGCTCATGACACGCTTAACCTACACCCTTGATGAGATTGAGGGACCATTCGAAGTGTCTTCTGATGGCACTGTTAAGTTTGAGGAGAAGGATGGAATTGATTATGCTGCTGTTACAGTTCAGCTTCCTGGTGGTGAGCGTGTGCCCTTCCTCTTCACTATCAAACAGCTAGTGGCAAGCGGCAAACCAGAAAGCTTTAGCGGTGAATTCCTTGTGCCATCATACAGAGGTTCATCCTTCCTTGACCCAAAGGGACGGGGTGGATCTACTGGCTATGACAACGCTGTTGCATTGCCTGCTGGAGGGAGAGGAGACGAGGAGGAGCTTGAGAAGGAGAACGTAAAGAATACTGCATCTTCTACAGGAAAGATCACCCTGAGTGTTACCCAGTGCAAGCCAGAGACCGGTGAGGTCATTGGAGTATTTGAGAGCATCCAGCCATCTGATACTGATCTCGGTGCAAAGGTCCCCAAGGATGTGAAAATCCAGGGTATCTGGTATGCCCAACTTGAATGA。
to pairNtOEP1After the gene is analyzed, the gene codes 332 amino acids, and the amino acid sequence is shown as SEQ ID NO.2, and specifically comprises the following steps:
MAASLQAAATLMQPTKVGVAPARNNLQLRSAQSVSKAFGVEPAAARLTCSLQTELKDLAQKCTDAAKVAGFALATSALVVSGANAEGVPKRLTFDEIQSKTYMEVKGTGTANQCPTIEGGVASFAFKPGKYNAKKFCLEPTSFTVKAESVNKNAPPDFQKTKLMTRLTYTLDEIEGPFEVSSDGTVKFEEKDGIDYAAVTVQLPGGERVPFLFTIKQLVASGKPESFSGEFLVPSYRGSSFLDPKGRGGSTGYDNAVALPAGGRGDEEELEKENVKNTASSTGKITLSVTQCKPETGEVIGVFESIQPSDTDLGAKVPKDVKIQGIWYAQLE。
example 2
Using the tobacco pigment content obtained in example 1NtOEP1Gene, the inventors further constructed a VIGS interference vector TRV2 for gene silencingNtOEP1The related construction process is briefly described as follows.
(1) Obtaining the fragment of interest
SelectingNTOEP1A specific nucleic acid segment (nucleotide sequence 153-522 of SEQ ID NO. 1) in the gene is a guide sequence of VIGS, a primer is designed, and the cDNA obtained in the implementation 1 is used as a template for PCR amplification to obtain a target gene segment.
NtOEP1When the gene silencing vector is constructed, the primer sequence used for PCR amplification is designed as follows:
NtOEP1-VI-F: 5'-TCGACGACAAGACCCTGCAGGCAAACTGAACTCAAGGACT -3',
NtOEP1-VI-R: 5'-TGAGGAGAAGAGCCCTGCAGAATCTCATCAAGGGTGTAGG-3';
among the above sequences, "TCGACGACAAGACCCTGCAG" partial sequence at the 5 'end of the F primer portion and "TGAGGAGAAGAGCCCTGCAG" at the 5' end of the R primer portion are the linker sequence of TRV2-LIC vector;
the relevant amplification system and the amplification procedure were as described in example 1, and the final amplified fragment length was 370 bp.
(2) Enzyme digestion and connection
Using restriction endonucleasesPstI, carrying out single enzyme digestion on TRV2-LIC plasmid, then utilizing Infusion ligase to connect the single enzyme digestion product of TRV2-LIC with the PCR amplification fragment in the step (1), and designing a 10 mu l treatment system as follows:
2 x Infusion ligase, 2 μ l;
TRV2-LIC Single restriction fragment, 2. mu.l
PCR amplified fragment, 6. mu.l;
at 50 deg.C for 15 min, and then on ice for 1-2 min.
(3) Transformation and screening
Transforming the ligation product in the step (2) into an Escherichia coli competent cell DH5 α, coating the Escherichia coli competent cell DH5 α on LB medium containing kanamycin (50 mg/L), carrying out overnight inverted culture at 37 ℃ for screening to form a single colony, and further carrying out sequencing identification to determine whether the recombination is correct, namely the recombination is interference TRV2-NtOEP1A recombinant vector.
Example 3
Based on example 2, the inventors further utilizedAgrobacterium mediated transgenic system and screeningNtOEP1Transgenic plants with gene silencing, combining plant phenotypes toNtOEP1Further analysis of gene function was performed. The specific process is briefly described as follows.
(1) Transforming agrobacterium and preparing infection liquid
The TRV2 prepared in example 2NtOEP1After GV3301 Agrobacterium-infected cells are transformed by the recombinant vector, LB plate (containing 50 mg/L kanamycin and 50 mg/L rifampicin) is coated, inverted and dark culture is carried out at 28 ℃ for 2-3 days, single colony is picked up, and colony PCR screening and carrying is carried outNtOEP1Agrobacterium of gene fragment is monoclonal;
as controls, TRV1, TRV2-LIC, and TRV2-PDS were also transformed with Agrobacterium, respectively.
Respectively contain TRV1, TRV2-LIC and TRV2-NtOEP1TRV2-PDS Agrobacterium tumefaciens single colony is inoculated into 5 ml LB culture medium (containing 50 mg/L kanamycin and 50 mg/L rifampicin), and is shake-cultured at 28 ℃ and 180 r/min overnight until OD is about 1.0; inoculating into 30 ml LB liquid culture medium for continuous culture, and shaking culturing at 28 deg.C overnight until OD is about 2.0;
centrifuging at 3900 r/min for 15 min to collect Agrobacterium, discarding the supernatant, adding injection buffer (10 mM MES, 10 mM MgCl) to each cell2250 mu M acetosyringone), adjusting the OD value to about 1.0, and standing at room temperature for 3-6 hours;
further to TRV2-LIC, TRV2-NtOEP1、TRV2-PDSAdding TRV1 suspension into the suspension in a medium volume, and mixing to obtain the final product.
(2) Plant infection
Selecting Bunsen tobacco seedlings growing for about 4 weeks (tobacco seeds are sown in seedling pots in advance for seedling culture, seedling division is carried out two weeks after germination, the seedlings are planted in plastic pots (10 cm multiplied by 10 cm) and are grown and cultured under the conditions of 22 ℃, 16 h illumination/8 h darkness), after grouping, selecting tobacco plants with consistent growth vigor and about 4-5 leaves, pressing agrobacterium tumefaciens suspension liquid containing different TRV recombinant plasmids into all unfolded leaves from the back of the leaves by a 1ml pinless sterile injector through a pressure filtration method, filling the whole leaves with bacterial liquid, and culturing in air humidity of 22 ℃ and 75%.
After inoculating for 2 weeks, collecting leaves and extracting RNA, detecting gene silencing efficiency by using real-time PCR, and measuring the content of pigment substances in the tobacco leaves by using high performance liquid chromatography.
The results of the gene expression level detection after gene silencing are shown in FIG. 1, and the results of the partial phenotype are shown in FIG. 2. The specific pigment content measurements are shown in the following table (unit: μ g/g):
Figure DEST_PATH_IMAGE001
as can be seen by comprehensive analysis, TRV2-NtOEP1In plantsNtOEP1The expression level of the gene is only about 15% of that of the control (FIG. 1), indicating that the silencing effect is significant. Phytoene Dehydrogenase (PDS) is one of rate-limiting enzymes affecting carotenoid synthesis, and tobacco silencing of the gene can cause leaf chlorosis and bleaching phenotype, and the gene is also used as a marker gene for detecting silencing efficiency at present. Positive control TRV2-PDSThe fresh leaves were completely bleached and completely green, indicating that the results obtained with our injection are truly reliable (fig. 2).NtOEP1After gene silencing, the new leaves are light yellow and have obvious green losing phenotype, and the negative control TRV2-LIC empty vector control plant new leaves have the same phenotype as the non-injected plants. In addition, TRV 2-induced silencing by virusesNtOEP1The plant content of neoxanthin, violaxanthin, lutein, chlorophyll a, chlorophyll b and β carotene was significantly reduced compared to the control plants (table 1), indicating thatNtOEP1The gene is related to the tobacco pigment content. These experimental results show that the pigment content in tobacco leaves can be adjusted significantly by a virus-induced gene silencing method.
SEQUENCE LISTING
<110> Zhengzhou tobacco institute of China tobacco general Co
<120> NtOEP1 gene influencing tobacco pigment content and application thereof
<130>none
<160>2
<170>PatentIn version 3.5
<210>1
<211>999
<212>DNA
<213>Nicotiana tabacum
<400>1
atggctgcct ctctacaagc agctgctact ctaatgcaac caacaaaggt tggtgttgcc 60
ccagctagaa acaacctgca gttgaggtct gctcaaagtg tgagcaaagc atttggtgtt 120
gaaccagctg cagctaggct tacttgctct ttgcaaactg aactcaagga cttggctcaa 180
aagtgcactg atgctgccaa ggttgctggt tttgctctgg ccacttctgc ccttgtcgtc 240
tcaggagcaa atgctgaagg agttccaaaa cgtctaacct tcgacgaaat tcaaagcaag 300
acatacatgg aagtaaaggg aactggaact gctaaccagt gccctacgat agaaggaggt 360
gttgccagct ttgccttcaa gccaggcaaa tacaatgcca agaaattctg cttagagccc 420
acatcattca cagtcaaggc agagagtgtg aacaagaatg cacccccaga tttccagaaa 480
accaagctca tgacacgctt aacctacacc cttgatgaga ttgagggacc attcgaagtg 540
tcttctgatg gcactgttaa gtttgaggag aaggatggaa ttgattatgc tgctgttaca 600
gttcagcttc ctggtggtga gcgtgtgccc ttcctcttca ctatcaaaca gctagtggca 660
agcggcaaac cagaaagctt tagcggtgaa ttccttgtgc catcatacag aggttcatcc 720
ttccttgacc caaagggacg gggtggatct actggctatg acaacgctgt tgcattgcct 780
gctggaggga gaggagacga ggaggagctt gagaaggaga acgtaaagaa tactgcatct 840
tctacaggaa agatcaccct gagtgttacc cagtgcaagc cagagaccgg tgaggtcatt 900
ggagtatttg agagcatcca gccatctgat actgatctcg gtgcaaaggt ccccaaggat 960
gtgaaaatcc agggtatctg gtatgcccaa cttgaatga 999
<210>2
<211>332
<212>PRT
<213>Nicotiana tabacum
<400>2
Met Ala Ala Ser Leu Gln Ala Ala Ala Thr Leu Met Gln Pro Thr Lys
1 5 10 15
Val Gly Val Ala Pro Ala Arg Asn Asn Leu Gln Leu Arg Ser Ala Gln
20 25 30
Ser Val Ser Lys Ala Phe Gly Val Glu Pro Ala Ala Ala Arg Leu Thr
35 40 45
Cys Ser Leu Gln Thr Glu Leu Lys Asp Leu Ala Gln Lys Cys Thr Asp
50 55 60
Ala Ala Lys Val Ala Gly Phe Ala Leu Ala Thr Ser Ala Leu Val Val
65 70 75 80
Ser Gly Ala Asn Ala Glu Gly Val Pro Lys Arg Leu Thr Phe Asp Glu
85 90 95
Ile Gln Ser Lys Thr Tyr Met Glu Val Lys Gly Thr Gly Thr Ala Asn
100 105 110
Gln Cys Pro Thr Ile Glu Gly Gly Val Ala Ser Phe Ala Phe Lys Pro
115 120 125
Gly Lys Tyr Asn Ala Lys Lys Phe Cys Leu Glu Pro Thr Ser Phe Thr
130 135 140
Val Lys Ala Glu Ser Val Asn Lys Asn Ala Pro Pro Asp Phe Gln Lys
145 150 155 160
Thr Lys Leu Met Thr Arg Leu Thr Tyr Thr Leu Asp Glu Ile Glu Gly
165 170 175
Pro Phe Glu Val Ser Ser Asp Gly Thr Val Lys Phe Glu Glu Lys Asp
180 185 190
Gly Ile Asp Tyr Ala Ala Val Thr Val Gln Leu Pro Gly Gly Glu Arg
195 200 205
Val Pro Phe Leu Phe Thr Ile Lys Gln Leu Val Ala Ser Gly Lys Pro
210 215 220
Glu Ser Phe Ser Gly Glu Phe Leu Val Pro Ser Tyr Arg Gly Ser Ser
225 230 235 240
Phe Leu Asp Pro Lys Gly Arg Gly Gly Ser Thr Gly Tyr Asp Asn Ala
245 250 255
Val Ala Leu Pro Ala Gly Gly Arg Gly Asp Glu Glu Glu Leu Glu Lys
260 265 270
Glu Asn Val Lys Asn Thr Ala Ser Ser Thr Gly Lys Ile Thr Leu Ser
275 280 285
Val Thr Gln Cys Lys Pro Glu Thr Gly Glu Val Ile Gly Val Phe Glu
290 295 300
Ser Ile Gln Pro Ser Asp Thr Asp Leu Gly Ala Lys Val Pro Lys Asp
305 310 315 320
Val Lys Ile Gln Gly Ile Trp Tyr Ala Gln Leu Glu
325 330

Claims (7)

1. Influencing the pigment content of tobaccoNtOEP1The gene is characterized by comprising 999 bp bases, wherein the 153 th-522 th nucleotide is a specific core fragment thereof, and the base sequence is shown as SEQ ID NO. 1.
2. The method of claim 1 for affecting tobacco color contentNtOEP1The application of gene in the regulation of leaf pigment content is characterized by utilizing gene silencing technology or gene overexpression method to regulateNtOEP1The gene expression quantity is used for regulating and controlling the content of the pigment substances in the leaves.
3. The method of claim 1 for affecting tobacco color contentNtOEP1The PCR amplification preparation method of the gene is characterized by comprising the following steps:
(1) extracting a tobacco sample genome, and carrying out reverse transcription to obtain cDNA for later use;
(2) designing a primer for PCR amplification, and carrying out PCR amplification, wherein the specific primer sequence is designed as follows:
NtOEP1-F: 5'- ATGGCTGCCTCTCTACAAGC -3',
NtOEP1-R: 5'- TCATTCAAGTTGGGCATACC -3'。
4. silencing of the effects on tobacco pigment content of claim 1NtOEP1Silencing vector TRV2-NtOEP1The vector is characterized by being constructed and obtained through the following steps:
(1) PCR amplification
To be provided withNtOEP1153 th-522 th nucleotide in the gene is used as a guide sequence of VIGS, and a primer sequence for designing and amplifying is designed as follows:
NtOEP1-VI-F: 5'-TCGACGACAAGACCCTGCAGGCAAACTGAACTCAAGGACT -3',
NtOEP1-VI-R: 5'-TGAGGAGAAGAGCCCTGCAGAATCTCATCAAGGGTGTAGG-3';
among the above sequences, "TCGACGACAAGACCCTGCAG" partial sequence at the 5 'end of the F primer portion and "TGAGGAGAAGAGCCCTGCAG" at the 5' end of the R primer portion are the linker sequence of TRV2-LIC vector;
(2) enzyme digestion and connection
Using restriction endonucleasesPstI, carrying out single enzyme digestion on the TRV2-LIC plasmid, and then utilizing Infusion ligase to connect the single enzyme digestion product of the TRV2-LIC with the PCR amplification fragment in the step (1);
(3) transformation and screening
Transforming the ligation product in the step (2) into an Escherichia coli competent cell DH5 α, coating the Escherichia coli competent cell DH5 α on an LB culture medium containing kanamycin, carrying out overnight inverted culture at 37 ℃ for screening to form a single colony, and further identifying to determine that the correct recombinant single clone is the TRV2-NtOEP1A recombinant vector.
5. The method of claim 1 for affecting tobacco color contentNtOEP1The protein coded by the gene is characterized by comprising 332 amino acids, and the amino acid sequence of the protein is shown as SEQ ID NO. 2.
6. The method of claim 5 for affecting tobacco color contentNtOEP1The application of the protein coded by the gene in regulating and controlling the content of the leaf pigments is characterized in that the protein is related to the content of the pigments in the plant leaves, and the content of the pigments in the leaves is obviously reduced after the expression content of the protein is reduced.
7. Use of the composition of claim 1 for influencing tobacco pigment contentNtOEP1A method for breeding a new tobacco variety of a gene, characterized in that the gene is disrupted, silenced, knocked out or overexpressed by a transgenic technique, a transient expression technique or a genome editing techniqueNtOEP1The gene can obtain a new variety of tobacco transformation plants with changed pigment content.
CN201911316510.9A 2019-12-19 2019-12-19 NtOEP1 gene influencing tobacco pigment content and application thereof Active CN110862445B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911316510.9A CN110862445B (en) 2019-12-19 2019-12-19 NtOEP1 gene influencing tobacco pigment content and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911316510.9A CN110862445B (en) 2019-12-19 2019-12-19 NtOEP1 gene influencing tobacco pigment content and application thereof

Publications (2)

Publication Number Publication Date
CN110862445A true CN110862445A (en) 2020-03-06
CN110862445B CN110862445B (en) 2022-04-26

Family

ID=69659265

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911316510.9A Active CN110862445B (en) 2019-12-19 2019-12-19 NtOEP1 gene influencing tobacco pigment content and application thereof

Country Status (1)

Country Link
CN (1) CN110862445B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111499712A (en) * 2020-06-04 2020-08-07 中国烟草总公司郑州烟草研究院 Tobacco NtDREB-1B L2 transcription factor and application thereof
CN114805513A (en) * 2022-05-05 2022-07-29 云南中烟工业有限责任公司 Tobacco NtOEE1 gene and application thereof in regulation of stem and leaf included angle and plant height

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015057571A2 (en) * 2013-10-14 2015-04-23 Mendel Biotechnology, Inc. Yield improvement in plants
CN107099540A (en) * 2017-07-06 2017-08-29 中国烟草总公司郑州烟草研究院 Influence NtFERL genes and its application of tobacco pigment content
CN107177604A (en) * 2017-07-06 2017-09-19 中国烟草总公司郑州烟草研究院 Influence NtWRKY69 genes and its application of tobacco pigment content
CN108517324A (en) * 2018-04-17 2018-09-11 中国烟草总公司郑州烟草研究院 One NtIPMD gene for influencing tobacco axillary bud differentiation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015057571A2 (en) * 2013-10-14 2015-04-23 Mendel Biotechnology, Inc. Yield improvement in plants
CN107099540A (en) * 2017-07-06 2017-08-29 中国烟草总公司郑州烟草研究院 Influence NtFERL genes and its application of tobacco pigment content
CN107177604A (en) * 2017-07-06 2017-09-19 中国烟草总公司郑州烟草研究院 Influence NtWRKY69 genes and its application of tobacco pigment content
CN108517324A (en) * 2018-04-17 2018-09-11 中国烟草总公司郑州烟草研究院 One NtIPMD gene for influencing tobacco axillary bud differentiation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GENBANK: "PREDICTED: Nicotiana tabacum oxygen-evolving enhancer protein 1, chloroplastic-like(LOC107766588), transcript variant X2, mRNA", 《GENBANK》 *
KOICHI SUGIHARA等: "Molecular Characterization of cDNA Encoding Oxygen Evolving Enhancer Protein 1 Increased by Salt Treatment in the Mangrove Bruguiera gymnorrhiza", 《PLANT CELL PHYSIOLOGY》 *
徐国云等: "类受体蛋白激酶NtFERL对烟草质体色素含量的影响", 《烟草科技》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111499712A (en) * 2020-06-04 2020-08-07 中国烟草总公司郑州烟草研究院 Tobacco NtDREB-1B L2 transcription factor and application thereof
CN114805513A (en) * 2022-05-05 2022-07-29 云南中烟工业有限责任公司 Tobacco NtOEE1 gene and application thereof in regulation of stem and leaf included angle and plant height

Also Published As

Publication number Publication date
CN110862445B (en) 2022-04-26

Similar Documents

Publication Publication Date Title
CN107936104B (en) Peony PsMYB12 transcription factor and coding gene and application thereof
CN107099540B (en) NtFERL gene influencing tobacco pigment content and application thereof
CN110205330B (en) Tobacco heat shock protein HSP22 and application thereof
CN110240640B (en) Tobacco AUX/IAA and application thereof
CN113621039A (en) Anthocyanin synthesis related protein IbMYB113 and coding gene and application thereof
CN110923251B (en) Tobacco polyphenol oxidase NtPPO4 and application thereof
CN110819639B (en) Tobacco low-temperature early-flowering related gene NtDUF599 and application thereof
CN110862445B (en) NtOEP1 gene influencing tobacco pigment content and application thereof
CN107177604B (en) NtWRKY69 gene influencing tobacco pigment content and application thereof
CN108517324B (en) NtIPMD gene affecting tobacco axillary bud differentiation
CN112143738B (en) Tobacco receptor protein gene and cloning method and application thereof
CN110938639B (en) Tobacco ATP synthase gamma chain NtATPG and application thereof
CN102586250A (en) Promoter of terpene floral scent gene Hctps1 in hedychium gardneranum and application of promoter
CN113461794B (en) Kit and method for regulating seed germination and application thereof
CN115058433B (en) Tobacco leaf yellowing regulatory gene NtMYB2, protein and application thereof
CN114230651A (en) Method for instantaneously changing color of dendrobium nobile by using DhMYB2 gene
CN114672494A (en) Application of tobacco NtEXB1 gene in plant branch development regulation
CN113151315A (en) Tobacco polyphenol metabolic pathway protein gene NtPOE and application thereof
CN110923244B (en) Tobacco mitochondrial RNA editing factor NtMEF1 and application thereof
CN110157717B (en) Tobacco transcriptional repressor OFP1 and application thereof
CN111019954B (en) Tobacco protein ACTB and application thereof
CN111019955B (en) Tobacco protein ZR-1 and application thereof
CN114990133B (en) Tobacco carotenoid metabolism related gene and application
CN110904067B (en) Tobacco chlorogenic acid synthetic gene NtHQT and application thereof
CN111304212B (en) Tobacco NtYcf45-like protein and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant